OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.19 USD
-0.09 (-7.03%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.18 -0.01 (-0.84%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OPK 1.19 -0.09(-7.03%)
Will OPK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OPK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPK
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics
OPK: What are Zacks experts saying now?
Zacks Private Portfolio Services
OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands
Other News for OPK
Q2 2025 OPKO Health Inc Earnings Call Transcript
Decoding OPKO Health Inc (OPK): A Strategic SWOT Insight
Here are the major earnings after the close Thursday
OPKO Health (OPK) Advances Strategic Initiatives with Key Asset Sale
OPKO Health outlines $640M–$660M 2025 revenue target as BioReference sale and pipeline advances drive profitability push